Home > > > Report Detail

Global Natural Killer Cell Therapy Market Growth (Status and Outlook) 2020-2025

Publisher Name :
Date: 15-Oct-2020
No. of pages: 117

According to this study, over the next five years the Natural Killer Cell Therapy market will register a 25.1%% CAGR in terms of revenue, the global market size will reach $ 404.8 million by 2025, from $ 165.3 million in 2019. In particular, this report presents the global revenue market share of key companies in Natural Killer Cell Therapy business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Natural Killer Cell Therapy market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Natural Killer Cell Therapy, covering the supply chain analysis, impact assessment to the Natural Killer Cell Therapy market size growth rate in several scenarios, and the measures to be undertaken by Natural Killer Cell Therapy companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.

- NK Cell Therapies

- NK Cell Directed Antibodies

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.

- Cancer

- Gastrointestinal Diseases

- Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Nektar Therapeutics

- NantKwest

- Innate Pharma SA

- Chipscreen Biosciences

- Glycostem Therapeutics

- Affimed

- Kiadis Pharma

- Fate Therapeutics

- Nkarta Therapeutics

- Dragonfly Therapeutics

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Natural Killer Cell Therapy market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Natural Killer Cell Therapy market by identifying its various subsegments.

- Focuses on the key global Natural Killer Cell Therapy players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Natural Killer Cell Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the size of Natural Killer Cell Therapy submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Natural Killer Cell Therapy Market Growth (Status and Outlook) 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Natural Killer Cell Therapy Market Size 2015-2025
2.1.2 Natural Killer Cell Therapy Market Size CAGR by Region
2.2 Natural Killer Cell Therapy Segment by Type
2.2.1 NK Cell Therapies
2.2.2 NK Cell Therapies
2.3 Natural Killer Cell Therapy Market Size by Type
2.3.1 Global Natural Killer Cell Therapy Market Size Market Share by Type (2015-2020)
2.3.2 Global Natural Killer Cell Therapy Market Size Growth Rate by Type (2015-2020)
2.4 Natural Killer Cell Therapy Segment by Application
2.4.1 Cancer
2.4.2 Gastrointestinal Diseases
2.4.3 Others
2.5 Natural Killer Cell Therapy Market Size by Application
2.5.1 Global Natural Killer Cell Therapy Market Size Market Share by Application (2015-2020)
2.5.2 Global Natural Killer Cell Therapy Market Size Growth Rate by Application (2015-2020)

3 Global Natural Killer Cell Therapy by Players
3.1 Global Natural Killer Cell Therapy Market Size Market Share by Players
3.1.1 Global Natural Killer Cell Therapy Market Size by Players (2018-2020)
3.1.2 Global Natural Killer Cell Therapy Market Size Market Share by Players (2018-2020)
3.2 Global Natural Killer Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Natural Killer Cell Therapy by Regions
4.1 Natural Killer Cell Therapy Market Size by Regions
4.2 Americas Natural Killer Cell Therapy Market Size Growth
4.3 APAC Natural Killer Cell Therapy Market Size Growth
4.4 Europe Natural Killer Cell Therapy Market Size Growth
4.5 Middle East & Africa Natural Killer Cell Therapy Market Size Growth

5 Americas
5.1 Americas Natural Killer Cell Therapy Market Size by Countries
5.2 Americas Natural Killer Cell Therapy Market Size by Type
5.3 Americas Natural Killer Cell Therapy Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Natural Killer Cell Therapy Market Size by Regions
6.2 APAC Natural Killer Cell Therapy Market Size by Type
6.3 APAC Natural Killer Cell Therapy Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Natural Killer Cell Therapy by Countries
7.2 Europe Natural Killer Cell Therapy Market Size by Type
7.3 Europe Natural Killer Cell Therapy Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Natural Killer Cell Therapy by Countries
8.2 Middle East & Africa Natural Killer Cell Therapy Market Size by Type
8.3 Middle East & Africa Natural Killer Cell Therapy Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Natural Killer Cell Therapy Market Forecast
10.1 Global Natural Killer Cell Therapy Market Size Forecast (2021-2025)
10.2 Global Natural Killer Cell Therapy Forecast by Regions
10.2.1 Global Natural Killer Cell Therapy Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Natural Killer Cell Therapy Forecast by Type
10.8 Global Natural Killer Cell Therapy Forecast by Application

11 Key Players Analysis
11.1 Nektar Therapeutics
11.1.1 Company Details
11.1.2 Natural Killer Cell Therapy Product Offered
11.1.3 Nektar Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Nektar Therapeutics News
11.2 NantKwest
11.2.1 Company Details
11.2.2 Natural Killer Cell Therapy Product Offered
11.2.3 NantKwest Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 NantKwest News
11.3 Innate Pharma SA
11.3.1 Company Details
11.3.2 Natural Killer Cell Therapy Product Offered
11.3.3 Innate Pharma SA Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Innate Pharma SA News
11.4 Chipscreen Biosciences
11.4.1 Company Details
11.4.2 Natural Killer Cell Therapy Product Offered
11.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Chipscreen Biosciences News
11.5 Glycostem Therapeutics
11.5.1 Company Details
11.5.2 Natural Killer Cell Therapy Product Offered
11.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Glycostem Therapeutics News
11.6 Affimed
11.6.1 Company Details
11.6.2 Natural Killer Cell Therapy Product Offered
11.6.3 Affimed Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Affimed News
11.7 Kiadis Pharma
11.7.1 Company Details
11.7.2 Natural Killer Cell Therapy Product Offered
11.7.3 Kiadis Pharma Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Kiadis Pharma News
11.8 Fate Therapeutics
11.8.1 Company Details
11.8.2 Natural Killer Cell Therapy Product Offered
11.8.3 Fate Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Fate Therapeutics News
11.9 Nkarta Therapeutics
11.9.1 Company Details
11.9.2 Natural Killer Cell Therapy Product Offered
11.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Nkarta Therapeutics News
11.10 Dragonfly Therapeutics
11.10.1 Company Details
11.10.2 Natural Killer Cell Therapy Product Offered
11.10.3 Dragonfly Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Dragonfly Therapeutics News

12 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Natural Killer Cell Therapy Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of NK Cell Therapies
Table 5. Major Players of NK Cell Directed Antibodies
Table 6. Natural Killer Cell Therapy Market Size by Type (2014-2019) ($ Millions)
Table 7. Global Natural Killer Cell Therapy Market Size Market Share by Type (2015-2020)
Table 8. Global Natural Killer Cell Therapy Market Size by Application (2015-2020) ($ Millions)
Table 9. Global Natural Killer Cell Therapy Market Size Market Share by Application (2015-2020)
Table 10. Global Natural Killer Cell Therapy Revenue by Players (2018-2020) ($ Millions)
Table 11. Global Natural Killer Cell Therapy Revenue Market Share by Players (2018-2020)
Table 12. Global Natural Killer Cell Therapy Key Players Head office and Products Offered
Table 13. Natural Killer Cell Therapy Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Natural Killer Cell Therapy Market Size by Regions 2015-2020 ($ Millions)
Table 17. Global Natural Killer Cell Therapy Market Size Market Share by Regions 2015-2020
Table 18. Americas Natural Killer Cell Therapy Market Size by Countries (2015-2020) ($ Millions)
Table 19. Americas Natural Killer Cell Therapy Market Size Market Share by Countries (2015-2020)
Table 20. Americas Natural Killer Cell Therapy Market Size by Type (2015-2020) ($ Millions)
Table 21. Americas Natural Killer Cell Therapy Market Size Market Share by Type (2015-2020)
Table 22. Americas Natural Killer Cell Therapy Market Size by Application (2015-2020) ($ Millions)
Table 23. Americas Natural Killer Cell Therapy Market Size Market Share by Application (2015-2020)
Table 24. APAC Natural Killer Cell Therapy Market Size by Regions (2015-2020) ($ Millions)
Table 25. APAC Natural Killer Cell Therapy Market Size Market Share by Regions (2015-2020)
Table 26. APAC Natural Killer Cell Therapy Market Size by Type (2015-2020) ($ Millions)
Table 27. APAC Natural Killer Cell Therapy Market Size Market Share by Type (2015-2020)
Table 28. APAC Natural Killer Cell Therapy Market Size by Application (2015-2020) ($ Millions)
Table 29. APAC Natural Killer Cell Therapy Market Size Market Share by Application (2015-2020)
Table 30. Europe Natural Killer Cell Therapy Market Size by Countries (2015-2020) ($ Millions)
Table 31. Europe Natural Killer Cell Therapy Market Size Market Share by Countries (2015-2020)
Table 32. Europe Natural Killer Cell Therapy Market Size by Type (2015-2020) ($ Millions)
Table 33. Europe Natural Killer Cell Therapy Market Size Market Share by Type (2015-2020)
Table 34. Europe Natural Killer Cell Therapy Market Size by Application (2015-2020) ($ Millions)
Table 35. Europe Natural Killer Cell Therapy Market Size Market Share by Application (2015-2020)
Table 36. Middle East & Africa Natural Killer Cell Therapy Market Size by Countries (2015-2020) ($ Millions)
Table 37. Middle East & Africa Natural Killer Cell Therapy Market Size Market Share by Countries (2015-2020)
Table 38. Middle East & Africa Natural Killer Cell Therapy Market Size by Type (2015-2020) ($ Millions)
Table 39. Middle East & Africa Natural Killer Cell Therapy Market Size Market Share by Type (2015-2020)
Table 40. Middle East & Africa Natural Killer Cell Therapy Market Size by Application (2015-2020) ($ Millions)
Table 41. Middle East & Africa Natural Killer Cell Therapy Market Size Market Share by Application (2015-2020)
Table 42. Key and Potential Regions of Natural Killer Cell Therapy
Table 43. Key Application and Potential Industries of Natural Killer Cell Therapy
Table 44. Key Challenges of Natural Killer Cell Therapy
Table 45. Key Trends of Natural Killer Cell Therapy
Table 46. Global Natural Killer Cell Therapy Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 47. Global Natural Killer Cell Therapy Market Size Market Share Forecast by Regions
Table 48. Global Natural Killer Cell Therapy Market Size Forecast by Type (2021-2025) ($ Millions)
Table 49. Global Natural Killer Cell Therapy Market Size Market Share Forecast by Type (2021-2025)
Table 50. Global Natural Killer Cell Therapy Market Size Forecast by Application (2021-2025) ($ Millions)
Table 51. Global Natural Killer Cell Therapy Market Size Market Share Forecast by Application (2021-2025)
Table 52. Nektar Therapeutics Details, Company Total Revenue (in $ million), Head Office, Natural Killer Cell Therapy Major Market Areas and Its Competitors
Table 53. Nektar Therapeutics Natural Killer Cell Therapy Product Offered
Table 54. Nektar Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin (2018-2020E)
Table 55. Nektar Therapeutics Main Business
Table 56. Nektar Therapeutics Latest Developments
Table 57. NantKwest Details, Company Total Revenue (in $ million), Head Office, Natural Killer Cell Therapy Major Market Areas and Its Competitors
Table 58. NantKwest Natural Killer Cell Therapy Product Offered
Table 59. NantKwest Main Business
Table 60. NantKwest Natural Killer Cell Therapy Revenue and Gross Margin (2018-2020E)
Table 61. NantKwest Latest Developments
Table 62. Innate Pharma SA Details, Company Total Revenue (in $ million), Head Office, Natural Killer Cell Therapy Major Market Areas and Its Competitors
Table 63. Innate Pharma SA Natural Killer Cell Therapy Product Offered
Table 64. Innate Pharma SA Main Business
Table 65. Innate Pharma SA Natural Killer Cell Therapy Revenue and Gross Margin (2018-2020E)
Table 66. Innate Pharma SA Latest Developments
Table 67. Chipscreen Biosciences Details, Company Total Revenue (in $ million), Head Office, Natural Killer Cell Therapy Major Market Areas and Its Competitors
Table 68. Chipscreen Biosciences Natural Killer Cell Therapy Product Offered
Table 69. Chipscreen Biosciences Main Business
Table 70. Chipscreen Biosciences Natural Killer Cell Therapy Revenue and Gross Margin (2018-2020E)
Table 71. Chipscreen Biosciences Latest Developments
Table 72. Glycostem Therapeutics Details, Company Total Revenue (in $ million), Head Office, Natural Killer Cell Therapy Major Market Areas and Its Competitors
Table 73. Glycostem Therapeutics Natural Killer Cell Therapy Product Offered
Table 74. Glycostem Therapeutics Main Business
Table 75. Glycostem Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin (2018-2020E)
Table 76. Glycostem Therapeutics Latest Developments
Table 77. Affimed Details, Company Total Revenue (in $ million), Head Office, Natural Killer Cell Therapy Major Market Areas and Its Competitors
Table 78. Affimed Natural Killer Cell Therapy Product Offered
Table 79. Affimed Main Business
Table 80. Affimed Natural Killer Cell Therapy Revenue and Gross Margin (2018-2020E)
Table 81. Affimed Latest Developments
Table 82. Kiadis Pharma Details, Company Total Revenue (in $ million), Head Office, Natural Killer Cell Therapy Major Market Areas and Its Competitors
Table 83. Kiadis Pharma Natural Killer Cell Therapy Product Offered
Table 84. Kiadis Pharma Main Business
Table 85. Kiadis Pharma Natural Killer Cell Therapy Revenue and Gross Margin (2018-2020E)
Table 86. Kiadis Pharma Latest Developments
Table 87. Fate Therapeutics Details, Company Total Revenue (in $ million), Head Office, Natural Killer Cell Therapy Major Market Areas and Its Competitors
Table 88. Fate Therapeutics Natural Killer Cell Therapy Product Offered
Table 89. Fate Therapeutics Main Business
Table 90. Fate Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin (2018-2020E)
Table 91. Fate Therapeutics Latest Developments
Table 92. Nkarta Therapeutics Details, Company Total Revenue (in $ million), Head Office, Natural Killer Cell Therapy Major Market Areas and Its Competitors
Table 93. Nkarta Therapeutics Natural Killer Cell Therapy Product Offered
Table 94. Nkarta Therapeutics Main Business
Table 95. Nkarta Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin (2018-2020E)
Table 96. Nkarta Therapeutics Latest Developments
Table 97. Dragonfly Therapeutics Details, Company Total Revenue (in $ million), Head Office, Natural Killer Cell Therapy Major Market Areas and Its Competitors
Table 98. Dragonfly Therapeutics Natural Killer Cell Therapy Product Offered
Table 99. Dragonfly Therapeutics Main Business
Table 100. Dragonfly Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin (2018-2020E)
Table 101. Dragonfly Therapeutics Latest Developments

List of Figures

Figure 1. Natural Killer Cell Therapy Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Natural Killer Cell Therapy Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Natural Killer Cell Therapy Market Size Market Share by Type (2015-2020)
Figure 5. Global NK Cell Therapies Market Size Growth Rate
Figure 6. Global NK Cell Directed Antibodies Market Size Growth Rate
Figure 7. Natural Killer Cell Therapy in Cancer
Figure 8. Global Natural Killer Cell Therapy Market: Cancer (2015-2020) ($ Millions)
Figure 9. Natural Killer Cell Therapy in Gastrointestinal Diseases
Figure 10. Global Natural Killer Cell Therapy Market: Gastrointestinal Diseases (2015-2020) ($ Millions)
Figure 11. Natural Killer Cell Therapy in Others
Figure 12. Global Natural Killer Cell Therapy Market: Others (2015-2020) ($ Millions)
Figure 13. Global Others YoY Growth ($ Millions)
Figure 14. Global Natural Killer Cell Therapy Market Size Market Share by Application in 2019
Figure 15. Global Natural Killer Cell Therapy Market Size Market Share by Regions 2015-2020
Figure 16. Americas Natural Killer Cell Therapy Market Size 2015-2020 ($ Millions)
Figure 17. APAC Natural Killer Cell Therapy Market Size 2015-2020 ($ Millions)
Figure 18. Europe Natural Killer Cell Therapy Market Size 2015-2020 ($ Millions)
Figure 19. Middle East & Africa Natural Killer Cell Therapy Market Size 2015-2020 ($ Millions)
Figure 20. Americas Natural Killer Cell Therapy Market Size Market Share by Countries in 2019
Figure 21. Americas Natural Killer Cell Therapy Market Size Market Share by Type in 2019
Figure 22. Americas Natural Killer Cell Therapy Market Size Market Share by Application in 2019
Figure 23. United States Natural Killer Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 24. Canada Natural Killer Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 25. Mexico Natural Killer Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 26. APAC Natural Killer Cell Therapy Market Size Market Share by Regions in 2019
Figure 27. APAC Natural Killer Cell Therapy Market Size Market Share by Type in 2019
Figure 28. APAC Natural Killer Cell Therapy Market Size Market Share by Application in 2019
Figure 29. China Natural Killer Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 30. Japan Natural Killer Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 31. Korea Natural Killer Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 32. Southeast Asia Natural Killer Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 33. India Natural Killer Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 34. Australia Natural Killer Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 35. Europe Natural Killer Cell Therapy Market Size Market Share by Countries in 2019
Figure 36. Europe Natural Killer Cell Therapy Market Size Market Share by Type in 2019
Figure 37. Europe Natural Killer Cell Therapy Market Size Market Share by Application in 2019
Figure 38. Germany Natural Killer Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 39. France Natural Killer Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 40. UK Natural Killer Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 41. Italy Natural Killer Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 42. Russia Natural Killer Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 43. Spain Natural Killer Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 44. Middle East & Africa Natural Killer Cell Therapy Market Size Market Share by Countries in 2019
Figure 45. Middle East & Africa Natural Killer Cell Therapy Market Size Market Share by Type in 2019
Figure 46. Middle East & Africa Natural Killer Cell Therapy Market Size Market Share by Application in 2019
Figure 47. Egypt Natural Killer Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 48. South Africa Natural Killer Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 49. Israel Natural Killer Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 50. Turkey Natural Killer Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 51. GCC Countries Natural Killer Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 52. Global Natural Killer Cell Therapy arket Size Forecast (2021-2025) ($ Millions)
Figure 53. Americas Natural Killer Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 54. APAC Natural Killer Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 55. Europe Natural Killer Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 56. Middle East & Africa Natural Killer Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 57. United States Natural Killer Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 58. Canada Natural Killer Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 59. Mexico Natural Killer Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 60. Brazil Natural Killer Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 61. China Natural Killer Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 62. Japan Natural Killer Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 63. Korea Natural Killer Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 64. Southeast Asia Natural Killer Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 65. India Natural Killer Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 66. Australia Natural Killer Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 67. Germany Natural Killer Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 68. France Natural Killer Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 69. UK Natural Killer Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 70. Italy Natural Killer Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 71. Russia Natural Killer Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 72. Spain Natural Killer Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 73. Egypt Natural Killer Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 74. South Africa Natural Killer Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 75. Israel Natural Killer Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 76. Turkey Natural Killer Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 77. GCC Countries Natural Killer Cell Therapy Market Size 2021-2025 ($ Millions)
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs